Clinical impact of the new criteria for the diagnosis of diabetes mellitus
| Autor: | Andrew F B Kernohan, Colin G Perry, Michael Small |
|---|---|
| Rok vydání: | 2003 |
| Předmět: |
medicine.medical_specialty
Resource planning Clinical Biochemistry World Health Organization World health Diabetes Complications Internal medicine Diabetes mellitus Epidemiology medicine Diabetes Mellitus Mass Screening National level Vascular Diseases Mass screening Glucose tolerance test medicine.diagnostic_test business.industry Biochemistry (medical) General Medicine Glucose Tolerance Test Impaired fasting glucose medicine.disease Endocrinology Phenotype business |
| Zdroj: | Clinical chemistry and laboratory medicine. 41(9) |
| ISSN: | 1434-6621 |
| Popis: | In 1997 the American Diabetes Association lowered the threshold for diagnosis of diabetes from a fasting plasma glucose concentration of 7.8 mmol/l to 7.0 mmol/l and advised that the oral glucose tolerance test no longer be used in routine clinical practice. In 1999 the World Health Organization endorsed the reduction in fasting plasma glucose threshold but recommended retaining the oral glucose tolerance test for anyone with impaired fasting glucose (6.1 mmol/l-6.9 mmol/l). This Review discusses the impact of these changes on the prevalence of diabetes and examines the implications for individuals and specific high-risk groups. The phenotype of those diagnosed with diabetes and the predictive value for the development of complications according to the different criteria are compared. It is clear that these changes in diagnostic criteria have major importance both for individuals and for resource planning at a national level. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|